CONSUN PHARMACEUTICAL GRP LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 1681 for the last semiannual is 1.37 B HKD, and it's 13.47% lower compared to the previous semiannual. The net income of H1 24 is 433.19 M HKD.